Opsoclonus myoclonus syndrome (NORD)

1,099views

test

00:00 / 00:00

Opsoclonus myoclonus syndrome (NORD)

ETP Endocrine System

ETP Endocrine System

Pharyngeal arches, pouches, and clefts
Endocrine system anatomy and physiology
Anatomy of the thyroid and parathyroid glands
Anatomy of the abdominal viscera: Pancreas and spleen
Pituitary gland histology
Thyroid and parathyroid gland histology
Pancreas histology
Adrenal gland histology
Synthesis of adrenocortical hormones
Adrenocorticotropic hormone
Growth hormone and somatostatin
Hunger and satiety
Antidiuretic hormone
Thyroid hormones
Insulin
Insulins
Glucagon
Somatostatin
Cortisol
Testosterone
Estrogen and progesterone
Oxytocin and prolactin
Parathyroid hormone
Calcitonin
Vitamin D
Phosphate, calcium and magnesium homeostasis
Congenital adrenal hyperplasia
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome
Conn syndrome
Pheochromocytoma
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal cortical carcinoma
Thyroglossal duct cyst
Hyperthyroidism
Hyperthyroidism: Pathology review
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Euthyroid sick syndrome
Hypothyroidism
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hypothyroidism and thyroiditis: Clinical
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid storm
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Diabetic nephropathy
Diabetic retinopathy
Pancreatic neuroendocrine neoplasms
Diabetes insipidus and SIADH: Pathology review
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hypopituitarism: Pathology review
Hypopituitarism
Hyperpituitarism
Pituitary adenoma
Pituitary apoplexy
Pituitary tumors: Pathology review
Sheehan syndrome
Hyperprolactinemia
Prolactinoma
Hypoprolactinemia
Gigantism
Acromegaly
Constitutional growth delay
Puberty and Tanner staging
Precocious puberty
Delayed puberty
Kallmann syndrome
Disorders of sex chromosomes: Pathology review
5-alpha-reductase deficiency
Menstrual cycle
Polycystic ovary syndrome
Premature ovarian failure
Menopause
Androgen insensitivity syndrome
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Hyperthyroidism medications
Hypothyroidism medications
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Adrenal hormone synthesis inhibitors

Assessments

USMLE® Step 1 questions

0 / 2 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

An 18-month-old boy is brought to the office by his parent due to abnormal body movements. His parent states that the patient has been walking abnormally for the past several weeks with frequent falls. The patient’s temperature is 37.0°C (98.6°F), pulse is 108/min, and blood pressure is 125/80 mmHg. Physical examination reveals multidirectional, nonrhythmic eye movements. The patient is also observed to have sporadic limb jerkings and truncal ataxia when walking. A left-sided immobile abdominal mass is palpated. There is no hepatosplenomegaly. Laboratory testing reveals anemia, and elevated levels of homovanillic acid and vanillylmandelic acid are detected in the urine. The abdominal mass most likely originated from which of the following embryologic derivatives?    

Transcript

Watch video only

Opsoclonus-myoclonus syndrome is also called OMS or dancing eyes-dancing feet syndrome.

Opsoclonus describes seemingly random, involuntary, and rapid eye movements in the horizontal, vertical, and diagonal directions.

Myoclonus describes lightening-like limb movements or limb jerks, that can also be more tremulous.

The syndrome also causes ataxia, which often results in the inability to walk, sit or crawl, and the loss of previously attained abilities, like speech.

Generally speaking, OMS is thought to be an autoimmune condition in which the body attacks the nervous system, resulting in the characteristic signs and symptoms.

The precise cause of OMS is unknown, but in children, it’s often due to a paraneoplastic syndrome.

The idea is that a hidden or occult tumor - like a neuroblastoma or ganglioneuroblastoma - triggers the body’s immune system, and the resulting antibodies unintentionally target healthy cells of the nervous system.

CD20+ B-cells that get into the CSF fluid seem to play an important role.

One brain area that gets affected is the cerebellum, which plays an important role in coordinating body movements.

In older children and adolescents OMS is thought to be triggered by an infection, and in adults, it’s often due to a paraneoplastic process due to lung or breast cancer, for example.

In children with OMS, there’s almost always ataxia, so it’s sometimes referred to as OMAS - with the A representing ataxia.

In fact, most toddlers with OMS are initially misdiagnosed with acute cerebellar ataxia of childhood.

The diagnosis of OMS is also often based on symptoms like opsoclonus and myoclonus which can appear abruptly, progressing over days to weeks.

Summary

Opsoclonus-myoclonus syndrome (OMS) is a rare condition, characterized by rapid, uncontrolled eye movements (opsoclonus) and sudden twitching or jerking of muscles (myoclonus). It can also present with ataxia, which often results in the inability to walk, sit or crawl, and the loss of previously attained abilities, like speech.

The cause of OMS is not well understood, but it is thought to be due to an autoimmune condition in which the body attacks the nervous system, resulting in characteristic signs and symptoms. Treatment involves immunosuppressive therapy like corticosteroids, intravenous immunoglobulin or IVIG, drugs like cyclophosphamide, and rituximab.